<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01723267</url>
  </required_header>
  <id_info>
    <org_study_id>rmcavibh-1</org_study_id>
    <nct_id>NCT01723267</nct_id>
  </id_info>
  <brief_title>Automated 3D (SonoAVC) Versus 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial</brief_title>
  <official_title>Automated 3D (SonoAVC) vs 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accurate assessment of the size of follicles is important in IVF treatment.Timing of oocyte
      maturation and subsequent egg collection is largely based on follicle size. An accurate
      assessment of follicle size and appropriate timing of HCG result in retrieval of more mature
      oocytes, improved fertilization and higher pregnancy rates. in 3D technology- fter the
      capturing of a 3D image of an ovary, SonoAVC automatically analyzes the volume dataset,
      identifies the boundaries of hypoechoic follicles, and provides estimates of their absolute
      dimensions. These measurements include the largest diameters in three orthogonal planes, the
      mean follicular diameter (MFD), the volume of the follicle, and the volume-based diameter
      (d(V)) of the follicle. In the current study the investigators aim to evaluate the use of
      this automated technique of follicle measurement vs. standard 2D technology on the timing of
      oocyte maturation and subsequent oocyte retrieval. The investigators speculate that 3D
      assessment will increase the rate of mature oocyte collection, and eventually will improve
      other treatment outcomes such as fertilization rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Not desired
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of matured oocytes</measure>
    <time_frame>one IVF cycle (within two weeks)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate in ICSI</measure>
    <time_frame>one IVF cycle/ patient (within two weeks)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>3D follicles assessment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>During IVF treatment all ultrasound examinations will use 3D- SonoAVC technology. Timing of hCG injection and oocyte collection will be based on follicle volume and 3D-volume based diameter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D follicles assessment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>During IVF treatment all ultrasound examinations will use standard 2D ultrasound. Timing of hCG injection and oocyte collection will be based on follicle diameter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3D follicles assessment</intervention_name>
    <description>3D ultrasound evaluation in IVF treatment (vs 2D ultrasound)</description>
    <arm_group_label>3D follicles assessment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2D follicles assessment</intervention_name>
    <description>2D ultrasound in IVF treatment (vs 3D ultrasound)</description>
    <arm_group_label>2D follicles assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age:18-39, cycle number 1-4

        Exclusion Criteria:

          -  PCOS

          -  Endometriosis

          -  Poor ovarian response

          -  TESA sperm
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avi Ben-Haroush, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVF Unit, Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2012</study_first_submitted>
  <study_first_submitted_qc>November 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2012</study_first_posted>
  <last_update_submitted>April 10, 2016</last_update_submitted>
  <last_update_submitted_qc>April 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>avi ben haroush</investigator_full_name>
    <investigator_title>Head of Fertility Preservation Service,IVF and Infertility Unit</investigator_title>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>3D ultrasound</keyword>
  <keyword>SonoAVC</keyword>
  <keyword>patients in IVF treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

